Hepatoprotection by dimethyl sulfoxide II. Characterization of optimal dose and the latest time of administration for effective protection against chloroform and bromobenzene induced injury

Citation
Rc. Lind et Aj. Gandolfi, Hepatoprotection by dimethyl sulfoxide II. Characterization of optimal dose and the latest time of administration for effective protection against chloroform and bromobenzene induced injury, EXP TOX PAT, 51(6), 1999, pp. 537-543
Citations number
19
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
ISSN journal
09402993 → ACNP
Volume
51
Issue
6
Year of publication
1999
Pages
537 - 543
Database
ISI
SICI code
0940-2993(199911)51:6<537:HBDS>2.0.ZU;2-R
Abstract
Dimethyl sulfoxide (DMSO) has previously been shown to attenuate chloroform (CHCl3) and bromobenzene (BB) induced hepatotoxicity in the rat when a dos e of 2.0 ml/kg is given 24 hr after the toxicants. However, the optimal dos e of DMSO and the latest time at which DMSO can be administered and still p rovide effective protection have not been determined. In order to determine the latest time at which DMSO can interrupt the development of necrosis, m ale Sprague Dawley rats received either 0.75 ml/kg CHCl3 or 0.5 ml/kg BB, 2 0% in corn oil, po, followed by single dose of 2 ml/kg DMSO, 50% in saline, ip, at 24, 26, 28 or 30 hr later. Positive control groups received either CHCl3 or BB and then 4.0 ml/kg saline, ip, 24 hr later. All of the animals were then killed 48 hr after toxicant dosing. The extent of liver injury pr esent when DMSO was administered was examined by killing animals at 24, 26, 28 or 30 hr after toxicant dosing. The optimal dose of DMSO for providing protection was estimated by administering either 0, 1.0, 2.0, 3.0 or 4.0 ml /kg DMSO at 24 hr after toxicant dosing and then killing the animals at 48 hr. Delaying DMSO administration to times later than 24 hr after toxicant d osing led to a loss of protection as indicated by both plasma ALT activity and the light microscopic appearance of liver tissue. The distinctive liver lesions present at 24 hr after CHCl3 or BB dosing rapidly expanded from be ing limited around central veins to bridging between centrilobular areas in only a few hours. This was accompanied by large increases in plasma ALT. W ith both toxicants, doses of DMSO greater than 2 ml/kg did not enhance its protective action while the lower dose of 1 ml/kg DMSO was not as effective . The loss of DMSO's antidotal action when given at times later than 24 hr after the toxicants indicates irreversible changes were underway as the cen trilobular lesions progressed from being limited to more bridging in nature . Hopefully, further elucidation of the mechanism(s) by which DMSO interrup ts the rapid progression of injury will both help to understand the steps i nvolved in lesion development and provide insights into therapeutic interve ntions for drug and chemical induced hepatitis.